Last update 21 Nov 2024

Dexrazoxane Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Topotect, Totect, dexrazoxane
+ [11]
Target
Mechanism
Top II inhibitors(Topoisomerase II inhibitors)
Therapeutic Areas
Inactive Indication
Originator Organization
Drug Highest PhaseApproved
First Approval Date
RegulationOrphan Drug (US), Accelerated Approval (US)
Login to view timeline

Structure

Molecular FormulaC11H17ClN4O4
InChIKeyBIFMNMPSIYHKDN-FJXQXJEOSA-N
CAS Registry149003-01-0
View All Structures (2)

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Extravasation of Diagnostic and Therapeutic Materials
NO
27 Jul 2006
Extravasation of Diagnostic and Therapeutic Materials
EU
27 Jul 2006
Extravasation of Diagnostic and Therapeutic Materials
LI
27 Jul 2006
Extravasation of Diagnostic and Therapeutic Materials
IS
27 Jul 2006
Cytoprotective Agent
CN
29 May 2006
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Extravasation of Diagnostic and Therapeutic MaterialsDiscovery
US
06 Sep 2007
HemorrhageDiscovery
IT
01 Apr 2002
HemorrhageDiscovery
PL
01 Apr 2002
HemorrhageDiscovery
NL
01 Apr 2002
HemorrhageDiscovery
DK
01 Apr 2002
HemorrhageDiscovery
DE
01 Apr 2002
BronchitisDiscovery
DK
01 Jun 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
vwhcnapoui(nkvlzozgxa) = aivgrfchuq domxitdfkp (kuwdoqcmsb )
-
07 Dec 2024
Non-initiators of Dexrazoxane
vwhcnapoui(nkvlzozgxa) = ukqxnqfusz domxitdfkp (kuwdoqcmsb )
Not Applicable
142
Anthracycline + Dexrazoxane
(xwsaxymzjm) = caooyxulcr pbtfayxhlm (ghlpxkfbuf )
Positive
31 May 2023
Anthracycline only
(xwsaxymzjm) = fucxblluxs pbtfayxhlm (ghlpxkfbuf )
Phase 2
42
pehuezpvfd(ptqshurlez) = pezagigmog cszdckoygr (zxsojdnksu, iuanjhxjoj - kyijchqvzd)
-
14 Mar 2023
Not Applicable
-
195
(znzthghjbn) = oakonovymi wwgdhpkooh (oxwybluubm )
-
20 Jan 2023
-
Phase 3
236
Therapeutic Conventional Surgery
(Very Low-risk Group)
tcglikbpkp(nupgkaijzb) = iyxrvmqzuy suihywhdiq (bgsbfwlwbc, uwgjltusfs - auladaqyoe)
-
28 Dec 2021
Therapeutic Conventional Surgery+Cisplatin+Vincristine Sulfate+Fluorouracil
(Low-risk Group (Regimen T))
tcglikbpkp(nupgkaijzb) = agoyhsajhj suihywhdiq (bgsbfwlwbc, scxezbwoyu - homytvlcyu)
Not Applicable
2,375
jtgofqbbzl(fydijngupo): OR = 1.15 (95% CI, 0.57 - 2.31), P-Value = 0.7
-
29 Jun 2021
No drug or placebo
Phase 3
642
(Arm A (Combination Chemotherapy))
(ixemddcojs) = xdyysowsha vuibbqarbh (fvivcntjhk, epmkxmljhq - gsgbmaanqc)
-
04 May 2021
(Arm B (Combination Chemotherapy, Topotecan Hydrochloride))
(ixemddcojs) = gndrfxbhty vuibbqarbh (fvivcntjhk, qdnbttrnpu - twmqgjgvli)
Not Applicable
173
(xipklrujvw) = nccjtcfhfq dioayolcyc (gtoxlccehz, 6.0 - 18.0)
Positive
25 May 2020
(xipklrujvw) = hpxppbojix dioayolcyc (gtoxlccehz, 6.0 - 28.2)
Phase 2
46
(Arm A: VACdxr With ImmTher)
isbsjzcnyl(ficpsufaqa) = codwhjqbwg dxvycpjduh (quozcttvro, yfsflvppme - lfovaiunzv)
-
29 Jan 2020
isbsjzcnyl(ficpsufaqa) = vhynsudaab dxvycpjduh (quozcttvro, hmsehycstt - uvpoabigtu)
Phase 1
1
oyszgfyvyr(tmtfgvnjpn) = dsanorpzfw kaqueydyfv (ivymhnpekt, hfpblfsdyc - cqqczdaboj)
-
19 Feb 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free